Stephen Yip
Stephen Yip
Vancouver General Hospital/BC Cancer/BCGSC
Verified email at vch.ca
Title
Cited by
Cited by
Year
ARID1A mutations in endometriosis-associated ovarian carcinomas
KC Wiegand, SP Shah, OM Al-Agha, Y Zhao, K Tse, T Zeng, J Senz, ...
New England Journal of Medicine 363 (16), 1532-1543, 2010
13972010
Distinct evolutionary trajectories of primary high‐grade serous ovarian cancers revealed through spatial mutational profiling
A Bashashati, G Ha, A Tone, J Ding, LM Prentice, A Roth, J Rosner, ...
The Journal of pathology 231 (1), 21-34, 2013
3322013
MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance
S Yip, J Miao, DP Cahill, AJ Iafrate, K Aldape, CL Nutt, DN Louis
Clinical cancer research 15 (14), 4622-4629, 2009
3322009
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
KR Taylor, A Mackay, N Truffaux, YS Butterfield, O Morozova, C Philippe, ...
Nature genetics 46 (5), 457-461, 2014
3252014
Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers
M Jansen, S Yip, DN Louis
The Lancet Neurology 9 (7), 717-726, 2010
2602010
Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers
S Yip, YS Butterfield, O Morozova, S Chittaranjan, MD Blough, J An, I Birol, ...
The Journal of pathology 226 (1), 7-16, 2012
2592012
The International Human Epigenome Consortium: a blueprint for scientific collaboration and discovery
HG Stunnenberg, S Abrignani, D Adams, M de Almeida, L Altucci, V Amin, ...
Cell 167 (5), 1145-1149, 2016
2172016
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells
H Wakimoto, G Mohapatra, R Kanai, WT Curry, S Yip, M Nitta, AP Patel, ...
Neuro-oncology 14 (2), 132-144, 2011
2002011
Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma
M Snuderl, A Batista, ND Kirkpatrick, CR de Almodovar, L Riedemann, ...
Cell 152 (5), 1065-1076, 2013
1832013
Detection, characterization, and inhibition of FGFR–TACC fusions in IDH wild-type glioma
AL Di Stefano, A Fucci, V Frattini, M Labussiere, K Mokhtari, P Zoppoli, ...
Clinical Cancer Research 21 (14), 3307-3317, 2015
1412015
Molecular diagnostic testing in malignant gliomas: a practical update on predictive markers
S Yip, AJ Iafrate, DN Louis
Journal of Neuropathology & Experimental Neurology 67 (1), 1-15, 2008
1102008
Disulfiram, a drug widely used to control alcoholism, suppresses self-renewal of glioblastoma and overrides resistance to temozolomide
J Triscott, C Lee, K Hu, A Fotovati, R Berns, M Pambid, M Luk, RE Kast, ...
Oncotarget 3 (10), 1112, 2012
1082012
Neural stem cell biology may be well suited for improving brain tumor therapies
S Yip, KS Aboody, M Burns, J Imitola, JA Boockvar, J Allport, KI Park, ...
The Cancer Journal 9 (3), 189-204, 2003
1052003
Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis
J Torchia, D Picard, L Lafay-Cousin, CE Hawkins, SK Kim, L Letourneau, ...
The lancet oncology 16 (5), 569-582, 2015
1022015
Integrated (epi)-genomic analyses identify subgroup-specific therapeutic targets in CNS rhabdoid tumors
J Torchia, B Golbourn, S Feng, KC Ho, P Sin-Chan, A Vasiljevic, ...
Cancer cell 30 (6), 891-908, 2016
992016
Mgmt methylation is a prognostic biomarker in elderly patients with newly diagnosed glioblastoma
ER Gerstner, S Yip, DL Wang, DN Louis, AJ Iafrate, TT Batchelor
Neurology 73 (18), 1509-1510, 2009
972009
Nucleic acid quantity and quality from paraffin blocks: defining optimal fixation, processing and DNA/RNA extraction techniques
G Turashvili, W Yang, S McKinney, S Kalloger, N Gale, Y Ng, K Chow, ...
Experimental and molecular pathology 92 (1), 33-43, 2012
932012
Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells
R Kanai, SD Rabkin, S Yip, D Sgubin, CM Zaupa, Y Hirose, DN Louis, ...
Journal of the National Cancer Institute 104 (1), 42-55, 2012
932012
ETV6-NTRK3 is expressed in a subset of ALK-negative inflammatory myofibroblastic tumors
AH Alassiri, RH Ali, Y Shen, A Lum, C Strahlendorf, R Deyell, R Rassekh, ...
The American journal of surgical pathology 40 (8), 1051-1061, 2016
822016
Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers
J Laskin, S Jones, S Aparicio, S Chia, C Ch'ng, R Deyell, P Eirew, A Fok, ...
Molecular Case Studies 1 (1), a000570, 2015
782015
The system can't perform the operation now. Try again later.
Articles 1–20